[Humoral immunity in human sarcomas]

Area of Science:

• Immunology
• Oncology

Context:

• Humoral immunity in sarcoma patients was investigated.
• Cytotoxic testing utilized a human mesenchymoma cell line.

Purpose:

• To assess serum and immunoglobulin fraction activity in sarcoma patients.
• To identify cytotoxic antibodies and their behavior during treatment.

Summary:

• 19S immunoglobulin fractions in patient serum contained cytotoxic antibodies, while 7S fractions were inactive.
• Whole serum showed cytotoxicity in most soft tissue sarcoma patients before treatment.
• Immunoglobulins exhibited specific binding to target cells, suggesting cytotoxic and potential blocking effects.
• Irradiation treatment did not reduce the cytotoxic activity of serum or its 19S fraction.

Impact:

• Findings contribute to understanding anti-tumor immunity in sarcoma.
• Highlights the role of 19S immunoglobulins in cytotoxic responses.
• Suggests potential for immunotherapy targeting immunoglobulin activity in sarcoma.